Potential 20-Week Faricimab Dosing in Wet Age-Related Macular Degeneration

Ophthalmology Retina 2026 Open access

Read full text
Authors: Aude Ambresin, Varun Chaudhary, Richard Gale, Adrian Hock Chuan Koh, Nikolas J. S. London, PJ Patel, Anna C.S. Tan, Hill LF, Aachal Kotecha, Philippe Margaron, Michael Singer, Ashkan Abbey
+88 more Elmira Abdulaeva, Prema Abraham, Alfredo Adan Civera, Hansjurgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Y Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin Brown, David M. Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Iksoo Byon, Carlo Cagini, J.M. Calzada, Stone Cameron, Peter Campochiaro, John Carlson, Angela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel Chao, Nauman Chaudhry, C P Chee, Andrew Cheek, Shih-Jen Chen, San-Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David Chow, Abosede Cole, Brian Connolly, Pierre Loic Cornut, Stephen Couvillion, Carl Danzig, Vesselin Daskalov, Amr Dessouki, Francois Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard Dreyer, Pravin Dugel, David Eichenbaum, Bora Eldem, Robert Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip Ferrone, Marta Figueroa, Howard Fine, Mitchell Fineman, Gregory M. Fox, Catherine Français, Pablo Franco, Samantha Fraser-Bell, Nicholas Fung, Federico Furno Sola, Richard Gale, Alfredo García‐Layana, Alfredo García‐Layana, Julie Gasperini, Maciej Gawęcki, Faruque Ghanchi, Manjot Gill
DOI: 10.1016/j.oret.2026.02.001
Cited by: 1
References: 6

Abstract

Patients with nAMD in TENAYA/LUCERNE always on extended faricimab dosing (≥12-weeks) achieved robust disease control throughout 2 years. Additionally, 56% of patients could have potentially extended to every-20-week dosing had the protocol allowed.

Fields of Study & Subjects

Retinal Diseases and Treatments Ophthalmology and Visual Impairment Studies Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
Ophthalmology Retina
Publisher
Elsevier BV
Volume
10
Issue
5
Pages
573–575
Publication date
7 February 2026
Language
EN